Fusen Pharmaceutical Company Limited
Research Fusen Pharmaceutical Company Limited (1652.HK) on Bullrun: market cap HKD 639.50M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1652.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 639.50M
- Financial periodFY2025
- RevenueCNY 273.37M
- Revenue growth-16.2%
- Net income-CNY 11.78M
- Free cash flowCNY 71.82M
- Gross margin40.2%
Valuation Snapshot
latest market cap is HKD 639.50M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 273.37M | -CNY 11.78M | CNY 71.82M | 40.2% | n/a | CNY 83.84M | CNY 301.23M | CNY 359.25M |
| FY2024 | CNY 326.03M | -CNY 188.78M | CNY 57.43M | 49.9% | -0.26 | CNY 21.06M | CNY 383.69M | CNY 369.67M |
| FY2023 | CNY 565.61M | -CNY 36.28M | -CNY 108.69M | 53.0% | -0.05 | CNY 34.85M | CNY 344.12M | CNY 563.52M |
| FY2022 | CNY 491.76M | -CNY 34.61M | CNY 86.63M | 45.8% | -0.05 | CNY 128.11M | CNY 228.38M | CNY 614.17M |
| FY2021 | n/a | n/a | n/a | n/a | 0.02 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 639.50M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
| Year | Dividends/share |
|---|---|
| FY2022 | 0 CNY |
| FY2021 | 0.01 CNY |
About Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Company Limited, an investment holding company, engages in the manufacturing and sale of pharmaceutical products in the People's Republic of China. The company offers Shuanghuanglian oral solutions and injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; Flunarizine hydrochloride capsules; Sanhuang tablets; compound ferrous sulfate granules; and other pharmaceutical products. It is also involved in manufacturing and sale of pharmaceutical package materials;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Fusen Pharmaceutical Company Limited's market cap?
Fusen Pharmaceutical Company Limited's market capitalization is HKD 639.50M.
What does Fusen Pharmaceutical Company Limited do?
Fusen Pharmaceutical Company Limited, an investment holding company, engages in the manufacturing and sale of pharmaceutical products in the People's Republic of China. The company offers Shuanghuanglian oral solutions and injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; Flunarizine hydrochloride capsules; Sanhuang tablets; compound ferrous sulfate granules; and other pharmaceutical products.